1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Route of Administration Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Aesthetic Medicine Market, by Product Type
8.1.1. Energy-Based Devices
8.1.1.1. Market Revenue and Forecast
8.1.2. Implants
8.1.2.1. Market Revenue and Forecast
8.1.3. Anti-Wrinkle Products
8.1.3.1. Market Revenue and Forecast
8.1.4. Dermal Fillers
8.1.4.1. Market Revenue and Forecast
8.1.5. Botulinum Toxin
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Aesthetic Medicine Market, by Procedure Type
9.1.1. Non-Invasive Procedure
9.1.1.1. Market Revenue and Forecast
9.1.2. Invasive Procedure
9.1.2.1. Market Revenue and Forecast
10.1. Aesthetic Medicine Market, by Application Type
10.1.1. Surgical
10.1.1.1. Market Revenue and Forecast
10.1.2. Non-Surgical
10.1.2.1. Market Revenue and Forecast
11.1. Aesthetic Medicine Market, by End-User Type
11.1.1. Medical Spas and Beauty Centres
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals and Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. Aesthetic Medicine Market, by Gender
12.1.1. Males
12.1.1.1. Market Revenue and Forecast
12.1.2. Females
12.1.2.1. Market Revenue and Forecast
13.1. Aesthetic Medicine Market, by Procedure Type
13.1.1. Oral
13.1.1.1. Market Revenue and Forecast
13.1.2. Topical
13.1.2.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product
14.1.2. Market Revenue and Forecast, by Procedure
14.1.3. Market Revenue and Forecast, by Application
14.1.4. Market Revenue and Forecast, by End-User
14.1.5. Market Revenue and Forecast, by Gender
14.1.6. Market Revenue and Forecast, by Route of Administration
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Product
14.1.7.2. Market Revenue and Forecast, by Procedure
14.1.7.3. Market Revenue and Forecast, by Application
14.1.7.4. Market Revenue and Forecast, by End-User
14.1.8. Market Revenue and Forecast, by Gender
14.1.8.1. Market Revenue and Forecast, by Route of Administration
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product
14.1.9.2. Market Revenue and Forecast, by Procedure
14.1.9.3. Market Revenue and Forecast, by Application
14.1.9.4. Market Revenue and Forecast, by End-User
14.1.10. Market Revenue and Forecast, by Gender
14.1.11. Market Revenue and Forecast, by Route of Administration
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product
14.2.2. Market Revenue and Forecast, by Procedure
14.2.3. Market Revenue and Forecast, by Application
14.2.4. Market Revenue and Forecast, by End-User
14.2.5. Market Revenue and Forecast, by Gender
14.2.6. Market Revenue and Forecast, by Route of Administration
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product
14.2.8.2. Market Revenue and Forecast, by Procedure
14.2.8.3. Market Revenue and Forecast, by Application
14.2.9. Market Revenue and Forecast, by End-User
14.2.10. Market Revenue and Forecast, by Gender
14.2.10.1. Market Revenue and Forecast, by Route of Administration
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Product
14.2.11.2. Market Revenue and Forecast, by Procedure
14.2.11.3. Market Revenue and Forecast, by Application
14.2.12. Market Revenue and Forecast, by End-User
14.2.13. Market Revenue and Forecast, by Gender
14.2.14. Market Revenue and Forecast, by Route of Administration
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Product
14.2.15.2. Market Revenue and Forecast, by Procedure
14.2.15.3. Market Revenue and Forecast, by Application
14.2.15.4. Market Revenue and Forecast, by End-User
14.2.16. Market Revenue and Forecast, by Gender
14.2.16.1. Market Revenue and Forecast, by Route of Administration
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Product
14.2.17.2. Market Revenue and Forecast, by Procedure
14.2.17.3. Market Revenue and Forecast, by Application
14.2.17.4. Market Revenue and Forecast, by End-User
14.2.18. Market Revenue and Forecast, by Gender
14.2.18.1. Market Revenue and Forecast, by Route of Administration
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product
14.3.2. Market Revenue and Forecast, by Procedure
14.3.3. Market Revenue and Forecast, by Application
14.3.4. Market Revenue and Forecast, by End-User
14.3.5. Market Revenue and Forecast, by Gender
14.3.6. Market Revenue and Forecast, by Route of Administration
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Product
14.3.7.2. Market Revenue and Forecast, by Procedure
14.3.7.3. Market Revenue and Forecast, by Application
14.3.7.4. Market Revenue and Forecast, by End-User
14.3.8. Market Revenue and Forecast, by Gender
14.3.9. Market Revenue and Forecast, by Route of Administration
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Product
14.3.10.2. Market Revenue and Forecast, by Procedure
14.3.10.3. Market Revenue and Forecast, by Application
14.3.10.4. Market Revenue and Forecast, by End-User
14.3.11. Market Revenue and Forecast, by Gender
14.3.11.1. Market Revenue and Forecast, by Route of Administration
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Product
14.3.12.2. Market Revenue and Forecast, by Procedure
14.3.12.3. Market Revenue and Forecast, by Application
14.3.12.4. Market Revenue and Forecast, by End-User
14.3.12.5. Market Revenue and Forecast, by Gender
14.3.12.6. Market Revenue and Forecast, by Route of Administration
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Product
14.3.13.2. Market Revenue and Forecast, by Procedure
14.3.13.3. Market Revenue and Forecast, by Application
14.3.13.4. Market Revenue and Forecast, by End-User
14.3.13.5. Market Revenue and Forecast, by Gender
14.3.13.6. Market Revenue and Forecast, by Route of Administration
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product
14.4.2. Market Revenue and Forecast, by Procedure
14.4.3. Market Revenue and Forecast, by Application
14.4.4. Market Revenue and Forecast, by End-User
14.4.5. Market Revenue and Forecast, by Gender
14.4.6. Market Revenue and Forecast, by Route of Administration
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Product
14.4.7.2. Market Revenue and Forecast, by Procedure
14.4.7.3. Market Revenue and Forecast, by Application
14.4.7.4. Market Revenue and Forecast, by End-User
14.4.8. Market Revenue and Forecast, by Gender
14.4.9. Market Revenue and Forecast, by Route of Administration
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Product
14.4.10.2. Market Revenue and Forecast, by Procedure
14.4.10.3. Market Revenue and Forecast, by Application
14.4.10.4. Market Revenue and Forecast, by End-User
14.4.11. Market Revenue and Forecast, by Gender
14.4.12. Market Revenue and Forecast, by Route of Administration
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Product
14.4.13.2. Market Revenue and Forecast, by Procedure
14.4.13.3. Market Revenue and Forecast, by Application
14.4.13.4. Market Revenue and Forecast, by End-User
14.4.13.5. Market Revenue and Forecast, by Gender
14.4.13.6. Market Revenue and Forecast, by Route of Administration
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Product
14.4.14.2. Market Revenue and Forecast, by Procedure
14.4.14.3. Market Revenue and Forecast, by Application
14.4.14.4. Market Revenue and Forecast, by End-User
14.4.14.5. Market Revenue and Forecast, by Gender
14.4.14.6. Market Revenue and Forecast, by Route of Administration
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product
14.5.2. Market Revenue and Forecast, by Procedure
14.5.3. Market Revenue and Forecast, by Application
14.5.4. Market Revenue and Forecast, by End-User
14.5.5. Market Revenue and Forecast, by Gender
14.5.6. Market Revenue and Forecast, by Route of Administration
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Product
14.5.7.2. Market Revenue and Forecast, by Procedure
14.5.7.3. Market Revenue and Forecast, by Application
14.5.7.4. Market Revenue and Forecast, by End-User
14.5.8. Market Revenue and Forecast, by Gender
14.5.8.1. Market Revenue and Forecast, by Route of Administration
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product
14.5.9.2. Market Revenue and Forecast, by Procedure
14.5.9.3. Market Revenue and Forecast, by Application
14.5.9.4. Market Revenue and Forecast, by End-User
14.5.9.5. Market Revenue and Forecast, by Gender
14.5.9.6. Market Revenue and Forecast, by Route of Administration
15.1. AbbVie Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Galderma
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Alma Lasers
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Cynosure
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Johnson & Johnson Private Limited
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Lumenis Be Ltd.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Solta Medical
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Candela Medical
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Hologic, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Dentsply Sirona
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client